点击图片查看原图
A2780/Taxol 人卵巢癌紫杉醇耐药株
T47D细胞人乳腺管癌细胞,ATCC细胞
AusGeneX,FBS500-S,特级（澳洲）胎牛
[VIP第1年] 指数:2
通过闵行区市场监督管理局认证 
过氧化氢酶-Catalase
溶菌酶干粉-Lysozyme 
小鼠抗V5标签单抗-Ant
鲑鱼精DNA溶液,10mg/m
JM107菌种-JM107 E.co
Human TAF13 (TATA Bo
MFC细胞小鼠前胃癌细| 货号： | YB-5449 |
| 生长状态： | 贴壁生长 |
| 年限： | 见说明书 |
| 运输方式： | 干冰运输or活细胞运输 |
| 器官来源： | 见说明书 |
| 是否是肿瘤细胞： | 见说明书 |
| 细胞形态： | 上皮样；多角形 |
| 免疫类型： | 请咨询销售人员 |
| 物种来源： | 人、大鼠、小鼠、、、、 |
| 组织来源： | 见说明书 |
| ATCC Number： | 详见官方网站 |
| 细胞类型： | 复苏 |
| 供应商： | 钰博生物 |
| 数量： | 大量 |
Synonyms Keratin, type I cytoskeletal 14, Cytokeratin-14, CK-14, Keratin-14, K14, KRT14, NFJ, CK14, EBS3, EBS4.
Introduction Cytokeratin 14 is a member of the keratin family, the most diverse group of intermediate filaments. Cytokeratin 14 is a type I keratin, is usually found as a heterotetramer with two keratin 5 molecules, a type II keratin. Together they form the cytoskeleton of epithelial cells. Mutations in the genes for these keratins are associated with epidermolysis bullosa simplex. At least one pseudogene has been identified at 17p12-p11.
Recombinant Human Cytokeratin 14Description Cytokeratin 14 Human Recombinant produced in E.Coli is a single, non-glycosylated polypeptide chain having a molecular mass of 51,530 Dalton.
The KRT14 is purified by proprietary chromatographic techniques.
Source Escherichia Coli.
Physical Appearance Sterile Filtered White lyophilized (freeze-dried) powder.
Formulation The protein (1mg/ml) was lyophilized after from a sterile solution containing 30mM Tris-HCL pH-8, 9.5M urea, 2mM DTT, 2mM EDTA and 10mM methylammonium chloride.
Solubility It is recommended to reconstitute the lyophilized CK-14 in sterile 18MΩ-cm H2O not less than 100µg/ml, which can then be further diluted to other aqueous solutions.
Recombinant Human Cytokeratin 14Stability Lyophilized KRT14 although stable at room temperature for 3 weeks, should be stored desiccated below -18℃. Upon reconstitution KRT14 should be stored at 4℃ between 2-7 days and for future use below -18℃.
For long term storage it is recommended to add a carrier protein (0.1% HSA or BSA).
Please prevent freeze-thaw cycles.
Purity Greater than 95.0% as determined by:
(a) Analysis by RP-HPLC.
(b) Analysis by SDS-PAGE.
Reconstitution to filaments Performed by mixing equimolar amounts of cytokeratins of type I and type II at concentrations of approx. 0.5 mg/ml, both dissolved in 9.5M urea buffer (see above). Protofilaments and filament complexes are obtained by dialyzing the resulting polypeptide solution stepwise to a concentration of 4M urea and then to low salt condition (50mM NaCI, 2mM dithiothreitol, 10mM Tris-HCI, pH 7.4). For immunization purposes, the solution can be further dialyzed against PBS (phosphate buffered saline, e.g. Dulbecco's PBS).
Recombinant Human Cytokeratin 14Usage CHI's products are furnished for LABORATORY RESEARCH USE ONLY. The product may not be used as drugs, agricultural or pesticidal products, food additives or household chemicals.
